Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRaydiant Oximetry, Inc.
About this trial
The objective of this study is to collect and compare fetal SpO2 waveforms and reference values to inform algorithm development for signal qualification and FSpO2 calculations. Subjects are women in labor.
Eligibility criteria
Qualifiers
Willing and capable of providing informed consent.
Age > 18 years.
Gestational age > 36 weeks.
Singleton pregnancy.
Disqualifiers
Age < 18 years.
Gestational age < 36 weeks
Multiple gestation
Nonvertex fetal presentation
Trial design
Treatments tested in this trial
- Fetal Pulse Oximetery
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov